EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

By George Bertsias, John P. A. Ioannidis, J. Boletis, S. Bombardieri, R. Cervera, C. Dostál, J. Font, I. Gilboe, F. Houssiau, T. Huizinga and 11 more. Annals of the Rheumatic Diseases, 2007

752 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/011fdae5ce002ed8d872283b60db66ef2e51b4d9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Ramos-Casals
2. G. Ruiz‐Irastorza
3. P. Brito-Zerón
4. M. Khamashta

Citations in the corpus

• Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review (2008, background): “and widely prescribed to patients with systemic lupus erythematosus (SLE). Current recommendations limit the indication of AMs to patients with non-major organ involvement,”